Australian, N.Z. Stocks: Brambles, CSR, Elders, Sonic Healthcare, Nuplex

Australia’s S&P/ASX 200 Index rose 0.1 percent to 4,385.30 at the close of trading in Sydney. New Zealand’s NZX 50 Index gained 0.4 percent to 3,000.11 in Wellington.

The following were among the most active shares in the market today. Stock symbols are in parentheses after company names.

Brambles Ltd. (BXB AU) slid 2.6 percent to A$6.10. The world’s biggest supplier of storage pallets was cut to “underperform” from “neutral” by Macquarie Group Ltd. analysts led by Russell Shaw.

CSR Ltd. (CSR AU) declined 0.9 percent to A$1.635. Bright Food Group Co.’s A$1.75 billion ($1.5 billion) offer for CSR’s sugar unit raises concerns that supplies of the refined sweetener may be diverted from the Australian market, Mackay Sugar Ltd. Chief Executive Officer Quinton Hildebrand said. Mackay owns 25 percent of Sugar Australia, the nation’s largest sugar refiner, with CSR owning the rest.

Dexion Ltd. (DEX AU) declined 2.2 percent to 67.5 Australian cents. The manufacturer of storage products was cut to “hold” from “buy” by Royal Bank of Scotland Group. The shares were unchanged at 69 Australian cents.

Elders Ltd. (ELD AU) tumbled 7 percent to 80 Australian cents. The world’s largest wool broker was cut to “hold” from “buy” at Royal Bank of Scotland.

Sonic Healthcare Ltd. (SHL AU) gained 3.4 percent to A$10.81. The Australian Financial Review reported that Quest Diagnostics Inc. has been considering buying the company. Chief Executive Officer Colin Goldschmidt declined to comment on the report. Rival Primary Health Care Ltd. (PRY AU) increased 2.9 percent to A$3.86.

New Zealand:

Nuplex Industries Ltd. (NPX NZ), a New Zealand resin manufacturer, rose 4 percent to NZ$2.88, the biggest gain in more than four months, after saying rising costs won’t reduce its earnings forecast.

To contact the reporters for this story: Kana Nishizawa in Tokyo at knishizawa5@bloomberg.net; Nichola Saminather in Sydney at Nsaminather1@bloomberg.net.

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.